within Pharmacolibrary.Drugs.ATC.A;

model A12CE02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.16666666666666666,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.00035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Sodium selenite is an inorganic form of selenium, an essential trace element required for selenoprotein synthesis in the human body. It is used for the treatment and prevention of selenium deficiency, parenteral nutrition supplementation, and has been investigated for use in oncology for its potential antineoplastic properties. Sodium selenite has been approved for clinical use as a micronutrient supplement but is not considered a first-line agent for any therapeutic indication beyond deficiency states.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for presumed healthy adult individuals, due to the absence of specific published compartmental pharmacokinetic data for sodium selenite.</p><h4>References</h4><ol><li>Xueying Zeng, Xiaotian Zhang, Bolin Fan, Yanmei Li, Ziming Jia, Wenyao Huang, Jiafa Liu, Gang Liu,Pharmacokinetics of Sodium Selenite in Rat Plasma and Tissues After Intragastric Administration.,Biological trace element research,2020<a href='https://pubmed.ncbi.nlm.nih.gov/31656014/'>https://pubmed.ncbi.nlm.nih.gov/31656014/</a></li><li>Priya Jayachandran, Susan J Knox, Maria Garcia-Cremades, Radojka M SaviÄ‡,Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic Cancer.,Drugs in R&D,2021<a href='https://pubmed.ncbi.nlm.nih.gov/33866531/'>https://pubmed.ncbi.nlm.nih.gov/33866531/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A12CE02;
